(Q34269632)

English

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

Alan R. Zinsmeister

11

object named as

Alan R Zinsmeister

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Michael Camilleri

1

object named as

Michael Camilleri

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

object named as

Archana S Rao

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

object named as

Banny S Wong

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

object named as

Sanna McKinzie

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

5

object named as

Duane Burton

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Maria I Vazquez-Roque

2

object named as

Maria Vazquez-Roque

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Johanna Iturrino

3

object named as

Johanna Iturrino

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

object named as

Amy Boldingh

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Enda Kenny

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Maria Månsson

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

19 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

303

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

G120-8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39).

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Performance characteristics of the measurement of gastric volume using single photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Integrated upper gastrointestinal response to food intake

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Human gastric emptying and colonic filling of solids characterized by a new method

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Towards a less costly but accurate test of gastric emptying and small bowel transit

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

The motility of the pelvic colon: Part II Paradoxical motility in diarrhoea and constipation

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

GLP-1: broadening the incretin concept to involve gut motility

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

The physiology of gastric emptying

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Stool form scale as a useful guide to intestinal transit time

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Glucagon like peptide-1 accelerates colonic transit via central CRF and peripheral vagal pathways in conscious rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Glucagon-like peptide 1 based therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00076.2012

21 January 2018

Identifiers

10.1152/AJPGI.00076.2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34269632&oldid=1834101628"